Laddar...
Inequality in treatment benefits: Can we determine if a new treatment benefits the many or the few?
In many randomized controlled trials, the primary analysis focuses on the average treatment effect and does not address whether treatment benefits are widespread or limited to a select few. This problem affects many disease areas, since it stems from how randomized trials, often the gold standard fo...
Sparad:
| I publikationen: | Biostatistics |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Oxford University Press
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6075268/ https://ncbi.nlm.nih.gov/pubmed/28025183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/biostatistics/kxw049 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|